Skip to Main Content

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Remember that no prescription is required. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day and please do stay in touch.

Seeking to push back on the negative image of the biopharmaceutical industry, executives representing over 150 small and mid-sized companies, along with investors and academics, signed an open letter outlining a commitment to place the interests of patients ahead of profits. However, the signatories do not include executives from the largest drug makers and biotechs. The letter, published in STAT, stated a commitment to “reasonable” price increases and achieving “broad patient access,” among other things.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!